ACHN
Achillion Pharmaceuticals
ACHN
ACHN
Delisted
ACHN was delisted on the 27th of January, 2020.
115 hedge funds and large institutions have $627M invested in Achillion Pharmaceuticals in 2014 Q2 according to their latest regulatory filings, with 41 funds opening new positions, 32 increasing their positions, 29 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
22% more funds holding
Funds holding: 94 → 115 (+21)
10% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 29
Holders
115
Holding in Top 10
3
Calls
$73.8M
Puts
$17.6M
Top Buyers
| 1 | +$43.9M | |
| 2 | +$43M | |
| 3 | +$17M | |
| 4 |
Invesco
Atlanta,
Georgia
|
+$3.5M |
| 5 |
Millennium Management
New York
|
+$3.32M |
Top Sellers
| 1 | -$40.3M | |
| 2 | -$25.9M | |
| 3 | -$8.94M | |
| 4 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$6.66M |
| 5 |
RA
Royce & Associates
New York
|
-$3.74M |